Protara Therapeutics to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Summary

Protara Therapeutics (Nasdaq: TARA) has announced its participation in two significant virtual investor conferences. The first is the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021, at 11:35 AM ET, followed by the Jefferies Virtual Healthcare Conference on June 2, 2021, at 1:30 PM ET. Investors can access live webcasts of the presentations on the Company's website, which will be archived for 90 days. Protara focuses on developing therapies for cancer and rare diseases, including its lead program, TARA-002.

NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at two upcoming virtual investor conferences:

• Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 11:35am ET
  
  
• Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30pm ET
  

A live audio webcast of the presentations can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcasts will be archived on the Company’s website for 90 days following the presentation.

About Protara Therapeutics, Inc.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

Company Contact:

Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836

FAQ

What are the dates of the upcoming investor conferences for Protara Therapeutics (TARA)?

Protara Therapeutics will present at the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021, and the Jefferies Virtual Healthcare Conference on June 2, 2021.

How can I access the presentations from Protara Therapeutics (TARA)?

The presentations can be accessed live via audio webcasts on Protara Therapeutics' website, and they will be archived for 90 days after the events.

What is the focus of Protara Therapeutics (TARA)?

Protara Therapeutics is dedicated to developing transformative therapies for cancer and rare diseases, with notable projects like TARA-002 for bladder cancer.